Transient inhibition of HNF4α initiates transformation of hepatocytes and downregulates miR-124, resulting in elevated IL-6/STAT3 signaling that promotes HCC development by further suppressing HNF4α through miR-24 and miR-629 [39]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.